Stryker Corporation

Stryker Corporation uses animal testing as part of its medical device development and regulatory compliance process. The company's product research includes studies on the effects of its surgical equipment, such as the Stryker Venom Cannula and Venom Electrode Combination, which have been documented in laboratory settings involving animals. Stryker also provides medical devices, like the Contour Neurovascular System, for in vitro testing using 3D-printed aneurysm models developed with animal tissue.

As a Fortune 500 medical technology company, Stryker's core business involves developing and manufacturing surgical, orthopedic, and neurotechnology devices, a sector where animal testing is often mandated by regulatory agencies like the FDA to demonstrate safety and efficacy. The company's 2023 Comprehensive Report acknowledges its position on animal research, indicating its ongoing engagement with this practice. Stryker's acquisition of companies like Invuity further integrates product lines whose development historically involved animal-based preclinical laboratory tests.